Squarepoint Ops LLC Cerus Corp Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Cerus Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 22,554 shares of CERS stock, worth $40,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,554

Holding current value

$40,371

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.39 $38,341 - $53,904	22,554 New	22,554 $39,000
Q1 2024 May 15, 2024	SELL	$1.66 - $2.42 $23,329 - $34,010	-14,054 Reduced 36.7%	24,245 $45,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.35 $47,873 - $90,002	38,299 New	38,299 $82,000
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $621,977 - $776,551	-184,017 Reduced 62.08%	112,413 $410,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $1.02 Million - $1.73 Million	296,430 New	296,430 $1.07 Million
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $73,206 - $94,454	-16,600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $561,240 - $815,607	-116,682 Reduced 87.55%	16,600 $91,000
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $477,235 - $633,916	79,939 Added 149.86%	133,282 $908,000
Q3 2021 Nov 15, 2021	SELL	$4.79 - $6.68 $423,162 - $590,131	-88,343 Reduced 62.35%	53,343 $325,000
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $58,331 - $69,234	10,903 Added 8.34%	141,686 $837,000
Q1 2021 May 17, 2021	SELL	$5.68 - $7.87 $305,322 - $423,043	-53,754 Reduced 29.13%	130,783 $786,000
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $25,289 - $41,233	-4,817 Reduced 2.54%	184,537 $1.28 Million
Q3 2020 Nov 16, 2020	SELL	$5.78 - $7.47 $1.09 Million - $1.41 Million	-188,861 Reduced 49.93%	189,354 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$4.5 - $7.02 $1.7 Million - $2.66 Million	378,215 New	378,215 $2.5 Million
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $310,292 - $593,556	-108,116 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.84 - $4.86 $415,165 - $525,443	108,116 New	108,116 $456,000
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $171,936 - $228,248	-33,321 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $64,719 - $94,762	-13,235 Reduced 28.43%	33,321 $169,000
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $110,260 - $124,503	-16,003 Reduced 25.58%	46,556 $336,000
Q2 2018 Aug 14, 2018	BUY	$5.19 - $7.25 $76,599 - $107,002	14,759 Added 30.88%	62,559 $417,000
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $79,601 - $128,346	22,360 Added 87.89%	47,800 $262,000
Q4 2017 Feb 14, 2018	BUY	$2.76 - $3.95 $70,214 - $100,488	25,440	25,440 $86,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

Baker Bros. Advisors LP New York, NY

19.5M
Shares

$34.9 Million
0.36% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

18.2M
Shares

$32.6 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$24.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$19.4 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.54M
Shares

$15.3 Million
0.01% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account